The new regulations, which govern the Patented Medicine Prices Review Board, will lower pharmaceutical industry profits by $2.9 billion over a decade, rather than the $8.8 billion anticipated previously.
Co-author Dr. David Fisman, of the University of Toronto's Dalla Lana school of public health, said the message of the study is that the choice to get vaccinated can't be thought of as merely personal.
The PromoVac strategy, developed in Sherbrooke by Dr. Arnaud Gagneur to convince parents who are hesitant about vaccination, will be deployed across Canada through a telehealth platform.
